Saudi Arabia inks deal with Houston firm for Alzheimer's research

05/02/2019 Argaam

 

Saudi Arabia signed an agreement with Houston-based Celltex Therapeutics Corporation, A&M for a multi-year research study on investigating therapies for Alzheimer's, the company said in a statement on Tuesday.

 

The investment will support research at A&M and is part of Saudi Arabia's National Industrial Development and Logistic Program (NILDP), it further added. 

Comments {{getCommentCount()}}

Be the first to comment

{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
{{comment.Replies.length}}
تعديل
loader Train
Report
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.